SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications신장 이식 환자에서 BNT162B2를 사용한 SARS-COV-2 백신 접종: 반응 장애 및 면역학적 영향에 대한 위험 요소Article Published on 2022-01-012022-09-11 Journal: Clinical transplantation [Category] MERS, SARS, 진단, 치료기술, [키워드] age Analysis antibody best BNT162b2 BNT162b2 vaccine coronavirus COVID-19 COVID-19 vaccination de novo Efficacy Factor Follow-up follow-up period graft rejection higher risk HLA-DSA immunological implication Infection intensity Italy kidney kidney transplant Kidney transplantation lack median metabolite metabolites Mild mRNA mRNA-based COVID-19 vaccine multivariable logistic regression Multivariable logistic regression analysis Organ transplant outcome Outpatient Patient patient age patients Post-vaccine pre-vaccination receiving rejection renal reported Rome SARS-CoV-2 Seroconversion seroconversion rate Solid solid organ solid organ transplant solid organ transplant patients. vaccination Vaccination strategy vaccine dose younger patient younger patients [DOI] 10.1111/ctr.14495 PMC 바로가기 [Article Type] Article
Clinically suspected myocarditis in COVID‐19 patients: Case series and review of the literatureCase Report Published on 2021-12-262022-11-01 Journal: Clinical Case Reports [Category] COVID-19, [키워드] acute respiratory syndrome Brain contributed coronavirus COVID‐19 COVID‐19 echocardiography Ejection fraction female Laboratory MONITOR myocarditis NT‐proBNP outcomes Patient peptide positive prohormone SARS‐CoV‐2 severe disease Treatment ventricular younger patient [DOI] 10.1002/ccr3.5236 PMC 바로가기 [Article Type] Case Report
COVID-19 Outcome Relates With Circulating BDNF, According to Patient Adiposity and AgeNutrition Published on 2021-12-102022-10-31 Journal: Frontiers in Nutrition [Category] COVID-19, [키워드] adiponectin adipose adipose tissue hormones age association BDNF blood sample BMI body composition body mass index cholesterol Clinical outcome collected Concentration concentrations COVID-19 COVID-19 severity died disease severity Endocrine evaluated fraction hormone Hormones Hospital staff Hospitalization hospitalized patient Intensive intensive care investigated Leptin male marker obesity older patients outcome parameter Patient patients patients hospitalized patients with COVID-19 performed predict predictor Prognosis Prospective Study receive Relate secreted serum Sex the disease tissue triglycerides while with COVID-19 worsened younger patient [DOI] 10.3389/fnut.2021.784429 PMC 바로가기 [Article Type] Nutrition
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment활성 치료 중인 암 환자에서 SARS-CoV-2 mRNA BNT162b2 백신에 대한 불량한 혈청 전환 및 유해 사례의 예측인자Observational Study Published on 2021-12-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, SARS, 바이오마커, 임상, 진단, [키워드] 95% CI Active surveillance active treatment adverse effects adverse event adverse events Antibody Response Antibody responses Antibody responses to the BNT162b2 vaccine benefit BNT162b2 BNT162b2 vaccine Cancer Cancer biological treatment cancer chemotherapy Cancer hormone therapy Cancer immunotherapy cancer patient Cancer patients Cancer target therapy candidate Chemotherapy ClinicalTrials conducted controls COVID-19 vaccine COVID-19 vaccine in cancer patients dose enrolled Factor female greater Hormone therapy IgG IgG response immunisation immunogenicity increasing age lack lymphocyte Lymphocyte count medications Mild mRNA BNT162b2 vaccine non-responders occur of BNT162b2 Older age Patient patients Patients with cancer predict predicted primary endpoint Prospective Study recruited responders risk S1/S2 SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccine adverse effects. second dose Seroconversion Serological testing significantly subject targeted therapy Therapies therapy Treatment women younger patient younger patients younger subject younger subjects [DOI] 10.1016/j.ejca.2021.09.030 PMC 바로가기 [Article Type] Observational Study
Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19)2019 코로나바이러스 감염증(COVID-19) 환자를 위한 렘데시비르의 80세 이상 환자 안전성Article Published on 2021-12-012022-09-11 Journal: Drugs & aging [Category] SARS, 치료제, [키워드] administration adverse event adverse events age Clinical practice comparable coronavirus disease Coronavirus disease 2019 COVID-19 defined evaluate evaluated Exacerbation fatigue high risk Hospitalization incidence liver dysfunction medication no significant difference no significant differences occurred Older older patient older patients Patient patients patients older patients with COVID-19 Remdesivir renal dysfunction required Safety suggested treated Treatment with COVID-19 Year younger patient younger patients [DOI] 10.1007/s40266-021-00908-9 PMC 바로가기 [Article Type] Article
Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case reportCase Report Published on 2021-11-082022-10-27 Journal: BMC Public Health [Category] Coronavirus, MERS, SARS, [키워드] Admission approach Artery bleeding Cardiogenic shock Cardiomyopathy Case report cause Combination Complete Course CT-scan discharged ECMO exceptional exclusion extracorporeal membrane oxygenation febrile female healthy Impella Infection Influenza influenza A virus initial invasive ventilation Local LVEF Mechanical circulatory support myocarditis neurological occurred Patient positive Prognosis recovery rehabilitation respiratory acidosis rising SARS-CoV-2 Shock submitted Support temperature treated Vascular ventricular was performed was tested while younger patient [DOI] 10.1186/s12872-021-02346-2 PMC 바로가기 [Article Type] Case Report
Fatal large-vessel cerebrovascular infarct presenting with severe coronavirus disease 2019 in a 39-year-old patient: a case reportCase Report Published on 2021-10-262022-10-30 Journal: Journal of Medical Case Reports [Category] COVID-19, MERS, SARS, [키워드] anticoagulation benefit blood test carotid Case report Coagulopathy coronavirus disease COVID-19 Critical diabete died Doppler ultrasound Evidence healthy highlight Interaction male Malignant stroke Patient patients presenting Research Respiratory illness risk factor serious complication severe coronavirus disease severity stroke the patient thrombosis unique Vascular younger patient [DOI] 10.1186/s13256-021-02991-3 PMC 바로가기 [Article Type] Case Report
COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptomsObservational Study Published on 2021-10-222022-10-04 Journal: Epidemiology and Infection [Category] MERS, SARS, 임상, [키워드] age Ageing analyses applied Care categories category conducted coronavirus coronavirus disease COVID-19 COVID-19 patient determine eight Epidemiology greater group hospital hospitals increasing age initial laboratory-confirmed Mexico City mortality risk Older age pandemic Patient performed presenting presenting symptom Regression model retrospective risk severity severity of symptom Symptom symptom onset Symptoms women younger patient [DOI] 10.1017/S095026882100234X PMC 바로가기 [Article Type] Observational Study
Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study—The COViNEPH ProjectArticle Published on 2021-10-122022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] age analyses analyzed Antigen applied BNT162b2 booster vaccination Chronic kidney disease Control Corticosteroid COVID-19 COVID19 determinant Efficacy Factor highest humoral IgG antibody immune response Immunosuppressant immunosuppressants immunosuppressive independent predictor Infection initial IQR kidney transplant recipient kidney transplant recipients longitudinal magnitude median age men mRNA mRNA vaccine mRNA vaccines mRNA-1273 mRNA-1273 vaccine naïve predictor protocol rate of seroconversion Responder response response to vaccination SARS-CoV-2 vaccination second dose Seroconversion seroconversion rate Transplant treated Treatment vaccination Vaccine younger patient [DOI] 10.3390/vaccines9101165 PMC 바로가기 [Article Type] Article
Clinical Course and Outcome of Patients with SARS-CoV-2 Alpha Variant Infection Compared to Patients with SARS-CoV-2 Wild-Type Infection Admitted to the ICUArticle Published on 2021-09-132022-10-29 Journal: Microorganisms [Category] COVID-19, [키워드] acute respiratory syndrome age and sex Alpha Alpha variant Analysis analyzed Characteristics clinical Clinical course coronavirus Course COVID-19 Critically ill patient epidemiological ICU ICUs Infection intensive care Intensive care medicine intensive care unit mechanical ventilation median age Mortality no significant difference Patient patients with SARS-CoV-2 positive required Result SARS-CoV-2 SARS-CoV-2 virus variant survival the SARS-CoV-2 Transmissibility variant VOCs wild-type wild-type SARS-CoV-2 younger patient [DOI] 10.3390/microorganisms9091944 PMC 바로가기 [Article Type] Article